3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
2
Active not recruiting
2
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neuroblastoma
3
Ovarian Neoplasms
2
Medulloblastoma
2
Lymphoma, B-Cell
2
Solid Tumor
1
Rhabdoid Tumor
1
Recurrence
1
Pyloric Stenosis, Hypertrophic
1
Pinealoma
1
Ovarian Germ Cell Cancer
1
Neuroectodermal Tumors, Primitive
1
Nervous System Neoplasms
1
Neoplasms, Germ Cell and Embryonal
1
Lymphoproliferative Disorders
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Glioma
1
Ganglioneuroblastoma
1
Ependymoma
1
Diffuse Intrinsic Pontine Glioma
1
Central Nervous System Neoplasms
1
Brain Neoplasms
1
Brain Diseases
1
Interventions
Etoposide
4
Cisplatin
4
lutetium Lu 177 dotatate
2
fludarabine phosphate
2
fludarabine
2
Cyclophosphamide
2
Bleomycin
2
repotrectinib
1
pegfilgrastim
1
etoposide phosphate
1
copper dotatate CU-64
1
Watchful Waiting
1
Vorinostat
1
Teniposide
1
Surveys and Questionnaires
1
Standard of Care
1
Specimen Handling
1
Respiratory Physiological Phenomena
1
Practice Guidelines as Topic
1
Platinum
1
Nivolumab
1
Mesna
1
Magnetic Resonance Spectroscopy
1
Lutetium-177
1
Lutetium
1
Injections
1
Immunotherapy
1
Filgrastim
1
Drug Therapy
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Neoplasms, Germ Cell and Embryonal
×
etoposide phosphate
×
Clear all
NCT02582697
2025-06-15
P3BEP
University of Sydney
Phase 3
Recruiting
500 enrolled